Table 4 Usage of treatment in the study patients according to sex
Variable | Total (N = 14,007) | Male (N = 11,020) | female (N = 2987) | P |
|---|---|---|---|---|
Inhaled/nebulized bronchodilators (beta-adrenoceptor agonist or muscarinic receptor antagonist) (n, %) | 9859(70.4) | 7925(71.9) | 1934(64.7) | < 0.001 |
Inhaled/nebulized corticosteroids (n, %) | 7850(56.0) | 6234(56.6) | 1616(54.1) | 0.016 |
Oral corticosteroids (n, %) | 1500(10.7) | 1254(11.4) | 246(8.2) | < 0.001 |
Intravenous corticosteroids (n, %) | 4982(35.6) | 4095(37.2) | 887(29.7) | < 0.001 |
Systemic corticosteroid (Oral or IV) | 5744(41.0) | 4722(42.8) | 1022(34.2) | < 0.001 |
Antibiotics (n, %) | 9088(64.9) | 7023(63.7) | 2065(69.1) | < 0.001 |
Theophylline drugs (n, %) | 7719(55.1) | 6127(55.6) | 1592(53.3) | 0.025 |
Non-invasive ventilation (n, %) | 2811(20.1) | 2130(19.3) | 681(22.8) | < 0.001 |
Invasive ventilation (n, %) | 462(3.3) | 334(3.0) | 128(4.3) | 0.001 |